Oracle Investment Management as of June 30, 2017
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 18 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 30.2 | $214M | 1.5M | 139.86 | |
| Accelr8 Technology Corporation | 18.2 | $129M | 4.7M | 27.35 | |
| Mazor Robotics Ltd. equities | 12.1 | $86M | 2.5M | 34.58 | |
| Quidel Corporation | 9.7 | $69M | 2.5M | 27.14 | |
| NxStage Medical | 9.7 | $69M | 2.7M | 25.07 | |
| Pacific Biosciences of California (PACB) | 4.2 | $29M | 8.3M | 3.56 | |
| Amarin Corporation (AMRN) | 3.6 | $26M | 6.4M | 4.03 | |
| Opko Health (OPK) | 3.4 | $24M | 3.6M | 6.58 | |
| Vermillion | 2.4 | $17M | 9.2M | 1.84 | |
| Intrexon | 2.3 | $17M | 689k | 24.09 | |
| Biolase Technology | 2.0 | $14M | 15M | 0.97 | |
| shares Agenus | 0.9 | $6.2M | 1.6M | 3.91 | |
| Epizyme | 0.6 | $4.4M | 292k | 15.10 | |
| Accelr8 Technology | 0.3 | $2.0M | 373k | 5.29 | |
| Biogen Idec (BIIB) | 0.2 | $1.7M | 6.4k | 271.36 | |
| Contrafect | 0.2 | $1.7M | 1.2M | 1.45 | |
| Second Sight Med Prods | 0.0 | $64k | 51k | 1.26 | |
| Aquabounty Technologies | 0.0 | $98k | 12k | 8.03 |
